Industry / United Kingdom
ABPI Hands Out Six Month Suspension For Roche
July 2008 | Industry NewsRoche has been suspended from the Association of the British Pharmaceutical Industry (ABPI) for a minimum of six months after the company was found to have seriously breached the association's code of practice. Roche has been rebuked for bringing discredit on the pharmaceutical industry.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
